Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Double-blind, Comparative, Controlled Trial of Tolerability, Safety and Immunogenicity of the Flu-M Vaccine in Children Between 6 Months and 9 Years Old

NCT05470582 is registered in ClinicalTrials.gov with St. Petersburg Research Institute of Vaccines and Sera as lead sponsor.

NCT NCT05470582
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05470582 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Double-blind, Comparative, Controlled Trial of Tolerability, Safety and Immunogenicity of the Flu-M Vaccine in Children Between 6 Months and 9 Years Old
Lead sponsor
St. Petersburg Research Institute of Vaccines and Sera
Phase
Phase 3
Overall status
Completed
Start date
February 16, 2021
Completion date
December 24, 2021
Enrollment
1,066 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

influenza, human, vaccination; infection, vaccines